
The ever-increasing rates of obesity and diabetes worldwide have the potential to further fuel the epidemic of cardiovascular disease that we are experiencing zzso To slow this epidemic zzso insulin resistance and associated zzso abnormalities that frequently accompany it are key clinical zzso Yet, we are still challenged to reach the mandated clinical goals for lipids that would minimize the development and progression of cardiovascular zzso zzso of a comprehensive approach by zzso in line with recent recommendations for stricter treatment goals for the zzso patient, is essential to achieving cardiovascular risk zzso The challenge for clinicians is zzso strategies, approaches and treatments that address the multiple zzso defects in patients with insulin resistance and zzso New perspectives can help effectively meet this ongoing zzso Emerging evidence suggests that zzso tissue is intimately involved in the zzso between insulin resistance and zzso The future probably involves therapeutic strategies that directly target zzso tissue to zzso reduce zzso zzso 

